iSpecimen Inc (ISPC) USD0.0001

Sell:$1.15Buy:$1.32$0.04 (2.88%)

Prices delayed by at least 15 minutes
Sell:$1.15
Buy:$1.32
Change:$0.04 (2.88%)
Deal now
Prices delayed by at least 15 minutes
Sell:$1.15
Buy:$1.32
Change:$0.04 (2.88%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

iSpecimen Inc. is a technology-driven company. The Company's iSpecimen Marketplace platform is designed to transform the biospecimen procurement process to accelerate medical discovery. The Company's technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. Its iSpecimen Marketplace platform has compiled de-identified healthcare data provided by its healthcare supply partners. The platform is built upon a robust healthcare data set comprised of information about available specimens and research subjects. The Company’s platform helps with administrative and reporting functions for researchers, suppliers, and its internal personnel, including user and compliance management. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data, administrative, compliance and reporting.

Key people

Katharyn Field
President
Robert Bradley Lim
Chief Executive Officer, Treasurer, Secretary, Director
Yuying Liang
Chief Financial Officer
Richard Paolone
Non-Executive Chairman of the Board, Independent Director
John L. Brooks
Independent Director
Avtar Dhaliwal
Independent Director
Siyun Yang
Independent Director
Click to see more

Key facts

  • EPIC
    ISPC
  • Location
    United States
  • Sector
    Technology
  • Industry
    Software & Programming
  • ISIN
    US45032V2079
  • Market cap
    $2.92m
  • Employees
    24
  • Shares in issue
    2.50m
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.